The assumption that klotho acts as a cardioprotective reagent is also supported by our in vitro data showing prevention of cardiac Fgf23-induced cardiac hypertrophy by sKL in NRVMs without altering high intra-cardiac Fgf23 expression and secretion. This evidence concerns the gene FGF23 and cardiac hypertrophy.